OncoLytika Ltd. is a technical consultancy company founded in 2010. We operate mainly in the biotechnology and pharmaceutical sector. Client companies include internationally located private and public limited companies operating in the diagnostics and therapeutic sectors as well as academia.
With innovation as a keystone principle for our company, the OncoLytika team delivers value to its clients through a variety of services ranging from opportunity recognition, technology strategy development, business planning, market evaluation and strategic planning for market entry. We have developed novel technical solutions and intellectual property for several clients in the biopharma and diagnostic space as well as providing technical writing and publication support.
OncoLytika has a track record of securing grant funding both at the national (UK Innovate) with and EU (Eurostar) level for its clients and provides project management and/or technical participation within consortia.
OncoLytika has a large and well developed network of contacts across the life-science sector and we can frequently be seen networking events organized by the Cambridge based One Nucleus and the OBN Ltd., both of which we have been members of since our inception.
We undertake both short term and longer term collaborative projects and have invested in early stage and developed companies. Our longer-term objective is to leverage these investments to fund OncoLytika's internal development programs which are focused on drug delivery.